Larchian WA - Search Results

1

Optimizing orthotopic bladder tumor implantation in a syngeneic mouse model.

Chan ES, Patel AR, Smith AK, Klein JB, Thomas AA, Heston WD, Larchian WA. Chan ES, et al. Among authors: larchian wa. J Urol. 2009 Dec;182(6):2926-31. doi: 10.1016/j.juro.2009.08.020. Epub 2009 Oct 20. J Urol. 2009. PMID: 19846165

2

Transabdominal micro-ultrasound imaging of bladder cancer in a mouse model: a validation study.

Patel AR, Chan ES, Hansel DE, Powell CT, Heston WD, Larchian WA. Patel AR, et al. Among authors: larchian wa. Urology. 2010 Apr;75(4):799-804. doi: 10.1016/j.urology.2009.06.047. Epub 2009 Sep 20. Urology. 2010. PMID: 19773032

3

In vivo targeted contrast enhanced micro-ultrasound to measure intratumor perfusion and vascular endothelial growth factor receptor 2 expression in a mouse orthotopic bladder cancer model.

Chan ES, Patel AR, Larchian WA, Heston WD. Chan ES, et al. Among authors: larchian wa. J Urol. 2011 Jun;185(6):2359-65. doi: 10.1016/j.juro.2011.02.047. Epub 2011 Apr 21. J Urol. 2011. PMID: 21511281

4

Sunitinib malate provides activity against murine bladder tumor growth and invasion in a preclinical orthotopic model.

Chan ES, Patel AR, Hansel DE, Larchian WA, Heston WD. Chan ES, et al. Among authors: larchian wa. Urology. 2012 Sep;80(3):736.e1-5. doi: 10.1016/j.urology.2012.04.038. Epub 2012 Jun 5. Urology. 2012. PMID: 22676953

5

Intravesical interleukin-12 gene therapy in an orthotopic bladder cancer model.

Horinaga M, Harsch KM, Fukuyama R, Heston W, Larchian W. Horinaga M, et al. Urology. 2005 Aug;66(2):461-6. doi: 10.1016/j.urology.2005.03.052. Urology. 2005. PMID: 16040105

6

Mouse orthotopic models for bladder cancer research.

Chan E, Patel A, Heston W, Larchian W. Chan E, et al. BJU Int. 2009 Nov;104(9):1286-91. doi: 10.1111/j.1464-410X.2009.08577.x. Epub 2009 Apr 16. BJU Int. 2009. PMID: 19388981 Review.

7

Novel enhanced lung-colonizing variant of murine MBT-2 bladder cancer cells.

Horinaga M, Fukuyama R, Nishiyama T, Harsch KM, Cicek M, Heston W, Sizemore N, Casey G, Larchian W. Horinaga M, et al. Urology. 2005 Sep;66(3):676-81. doi: 10.1016/j.urology.2005.03.073. Urology. 2005. PMID: 16140114

8

Intravesical liposome-mediated interleukin-2 gene therapy in orthotopic murine bladder cancer model.

Horiguchi Y, Larchian WA, Kaplinsky R, Fair WR, Heston WD. Horiguchi Y, et al. Among authors: larchian wa. Gene Ther. 2000 May;7(10):844-51. doi: 10.1038/sj.gt.3301157. Gene Ther. 2000. PMID: 10845722

9

Effectiveness of combined interleukin 2 and B7.1 vaccination strategy is dependent on the sequence and order: a liposome-mediated gene therapy treatment for bladder cancer.

Larchian WA, Horiguchi Y, Nair SK, Fair WR, Heston WD, Gilboa E. Larchian WA, et al. Clin Cancer Res. 2000 Jul;6(7):2913-20. Clin Cancer Res. 2000. PMID: 10914741

10

Isolation and characterization of a novel human bladder cancer cell line: BK10.

Roberson KM, Yancey DR, Padilla-Nash H, Edwards DW, Nash W, Jacobs S, Padilla GM, Larchian WA, Robertson CN. Roberson KM, et al. Among authors: larchian wa. In Vitro Cell Dev Biol Anim. 1998 Jul-Aug;34(7):537-44. doi: 10.1007/s11626-998-0113-y. In Vitro Cell Dev Biol Anim. 1998. PMID: 9719413

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

13 results

Search Page

Filters